MARC Record from Scriblio

LEADER: 02158nam 2200277 a 4500
001 97078239
003 DLC
005 19990211091426.4
008 980612s1998 nyua b 001 0 eng d
010 $a 97078239
020 $a0879695293
035 $a(OCoLC)39315192
040 $aNNU-M$cNNU-M$dCU$dDLC
042 $alccopycat
050 04 $aRC280.B5$bB633 1998
082 00 $a616.99/462$221
245 00 $aBladder cancer /$cguest editors, R.T.D. Oliver, M.J. Coptcoat.
260 $aPlainview, N.Y. :$bCold Spring Harbor Laboratory Press,$c1998.
300 $avi, 170 p. :$bill. (some col.) ;$c27 cm.
440 0 $aCancer surveys,$x0261-2429 ;$vv. 31
504 $aIncludes bibliographical references and index.
505 00 $tClonal evolution in bladder cancer : a scientific and clinical perspective /$rR.T.D. Oliver, M.J. Coptcoat --$tRisk factors in clonal development from superficial to invasive bladder cancer /$rJaime Landman, Michael J. Droller --$tSquamous change in bladder cancer and its relevance to understanding clonal evolution in development of bladder cancer /$rS. Baithun, P. Daruwala, R.T.D. Oliver --$tMalignancy associated papillomaviruses and morphology of human bladder cancer /$rR.T.D. Oliver ... [et al.] --$tMolecular genetics of bladder cancer : pathways of develoment and progression /$rMargaret A. Knowles --$tMolecular biological changes in bladder cancer /$rKhaver N. Qureshi, John Lunec, David E. Neal --$tClinical evaluation of immunotherapy : are there differences between papillary and flat in situ bladder cancer? /$rDonald L. Lamm --$tClonal development of bladder cancer and its relevance to the clinical potential of HLA antigen and TP53 based gene therapy /$rA.M.E. Nouri, R.T.D. Oliver, V.H. Nargund --$tRole of surgery in the multimodality treatment of bladder cancer /$rMalcolm J. Coptcoat, R.T.D. Oliver --$tRadiotherapy and chemotherapy for invasive bladder cancer /$rMiland Javle, Derek Raghavan --$tFuture directions /$rMalcolm J. Coptcoat, R.T.D. Oliver.
650 0 $aBladder$xCancer.
650 2 $aBladder Neoplasms.
700 1 $aOliver, R. T. D.$q(Roderick Timothy Desmond)
700 1 $aCoptcoat, Malcolm J.